Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to $158000.0.

  • Q32 Bio's Amortizatization of Intangibles rose 748.3% to $158000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $611000.0, marking a year-over-year increase of 700.53%. This contributed to the annual value of $579000.0 for FY2024, which is 643.38% up from last year.
  • As of Q3 2025, Q32 Bio's Amortizatization of Intangibles stood at $158000.0, which was up 748.3% from $155000.0 recorded in Q2 2025.
  • Q32 Bio's 5-year Amortizatization of Intangibles high stood at $1.6 million for Q4 2021, and its period low was -$252000.0 during Q2 2021.
  • Over the past 5 years, Q32 Bio's median Amortizatization of Intangibles value was $141000.0 (recorded in 2024), while the average stood at $233052.6.
  • Within the past 5 years, the most significant YoY rise in Q32 Bio's Amortizatization of Intangibles was 15570000.0% (2021), while the steepest drop was 635000.0% (2021).
  • Over the past 5 years, Q32 Bio's Amortizatization of Intangibles (Quarter) stood at $1.6 million in 2021, then crashed by 31.0% to $1.1 million in 2022, then plummeted by 87.07% to $139000.0 in 2023, then rose by 5.76% to $147000.0 in 2024, then increased by 7.48% to $158000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $158000.0 for Q3 2025, versus $155000.0 for Q2 2025 and $151000.0 for Q1 2025.